Seasonal malaria chemoprevention (SMC) is a highly effective intervention to prevent malaria in those most vulnerable to the disease's effects. It involves administering monthly doses of antimalarial drugs to children aged 3-59 months during peak malaria transmission season.
Our SMC programme in Burkina Faso, Chad and Nigeria is top rated by GiveWell for its effectiveness.
We strive to continuously improve quality of SMC implementation and to contribute to the evidence base through monitoring and evaluation (M&E) and research. Read more about our work here: